Application of needle electrodes in en bloc resection of single bladder tumor
Background: Transurethral resection of bladder tumor is associated with some limitations when used in the diagnosis and treatment of non-muscle invasive bladder cancer. Objectives: This study explored the application of needle electrodes in the transurethral resection of single bladder tumor (SBT) and highlighted the advantages of en bloc resection of bladder tumors. Methods: A retrospective analysis was conducted on 79 patients with SBT treated at the Department of Urology, People’s Liberation Army General Hospital, from January to December 2023. Among the patients, 64 (81.0%) were male, and 15 (19.0%) were female, with a mean age of 62.6 years. Among the patients, 68 (86.1%) had primary tumors, 11 (13.9%) had recurrent tumors, and 2 (2.5%) had SBTs following upper urothelial carcinoma radical resection. All patients underwent transurethral resection of bladder tumors using needle electrodes. Results: All procedures were successfully completed. The mean operation time lasted 51.0 min, and the mean blood loss was 7.9 mL. The median tumor size was 2 cm. The obturator nerve block was employed in 22 (33.8%) cases. The incidence of obturator nerve reflex was 40.9% (9/22) and 23.3% (10/43) without (p = 0.139). Post-operative complications included bladder tamponade in one patient (1.3%). The accuracy of muscle invasion reporting was 89.9%. Three patients were lost to follow-up, and two patients (2.6%) suffered from recurrence at 6 months. The median follow-up time was 13 months. Conclusion: Needle electrode resection for SBTs was highly safe, had low complication rates, and offered accurate tumor staging, resulting in precise treatment and low postoperative recurrence.
- Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 2017;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010
- Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001
- Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990-2013. Eur Urol. 2017;71(3):437-46. doi: 10.1016/j.eururo.2016.10.008
- Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: A review. JAMA. 2020;324(19):1980-91. doi: 10.1001/jama.2020.17598
- Baumeister P, Zamboni S, Mattei A, et al. Histological variants in non-muscle invasive bladder cancer. Transl Androl Urol. 2019;8(1):34-38. doi: 10.21037/tau.2019.01.09
- Akand M, Muilwijk T, Raskin Y, De Vrieze M, Joniau S, Van Der Aa F. quality control indicators for transurethral resection of non-muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;17(4):e784-e792. doi: 10.1016/j.clgc.2019.04.014
- Onishi T, Sugino Y, Shibahara T, Masui S, Yabana T, Sasaki T. Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int. 2017;119(2):276-82. doi: 10.1111/bju.13599
- Hayashida Y, Miyata Y, Matsuo T, et al. A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer. BMC Urol. 2019;19(1):56. doi: 10.1186/s12894-019-0486-0
- Song YP, McWilliam A, Hoskin PJ, Choudhury A. Organ preservation in bladder cancer: An opportunity for truly personalized treatment. Nat Rev Urol. 2019;16(9):511-522. doi: 10.1038/s41585-019-0199-x
- Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): A review of the literature and a practical approach to therapy. BJU Int. 2013;112(1):13-25. doi: 10.1111/j.1464-410X.2012.11762.x
- Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol. 2000;163(3):878-879.
- Zheng P, Zhang J, Zhu Y, et al. Comparative analysis of the efficacy of transurethral bipolar plasma needle electrode and ring electrode in the treatment of non-muscle-invasive bladder cancer. Comput Intell Neurosci. 2022;2022:6044676. doi: 10.1155/2022/6044676
- Sun S, Wang H, Zhang X, Chen G. Transurethral resection of bladder tumor: Novel techniques in a new era. Bladder (San Franc). 2023;10:e21200009. doi: 10.14440/bladder.2023.865
- Dutta SC, Smith JA Jr., Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 2001;166(2):490-493.
- Mori K, D’Andrea D, Enikeev DV, Egawa S, Shariat SF. En bloc resection for nonmuscle invasive bladder cancer: Review of the recent literature. Curr Opin Urol. 2020;30(1):41-47. doi: 10.1097/MOU.0000000000000697
- Liu H, Wu J, Xue S, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res. 2013;41(4):984-92. doi: 10.1177/0300060513477001
- Hurle R, Lazzeri M, Colombo P, et al. “En bloc” resection of nonmuscle invasive bladder cancer: A prospective single-center study. Urology. 2016;90:126-30. doi: 10.1016/j.urology.2016.01.004
- Kweon TD, Lee KY. Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer. Transl Androl Urol. 2018;7(2):283-286. doi: 10.21037/tau.2018.03.13
- Koumpan Y, Jaeger M, Mizubuti GB, et al. Spinal anesthesia is associated with lower recurrence rates after resection of nonmuscle invasive bladder cancer. J Urol. 2018; 199(4):940-946. doi: 10.21037/tau.2018.03.13